What the Study Found (In Plain English)
Published in Clinical autonomic research : official journal of the Clinical Autonomic Research Society (2026), this phase iii randomized trial evaluating 184 human participants investigated: Neurogenic orthostatic hypotension (nOH) causes disabling symptoms that impair daily function and quality of life. Key clinical takeaway: These MCID thresholds for the OHQ, OHSA and OHSA item 1 alone, enhance the interpretability of scores and support their use in evaluating clinical benefit.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Primary Endpoint & Quantitative Summary (Clinical autonomic research : official journal of the Clinical Autonomic Research Society, 2026-02-15; N = 184; Rigor 88/100): These MCID thresholds for the OHQ, OHSA and OHSA item 1 alone, enhance the interpretability of scores and support their use in evaluating clinical benefit.
Study Limitations & Caveats Before You Act
Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Phase III Randomized Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.